| Durvalumab/Tremelimumab Regimen studied in …STUDIED_INderived14 of 14show fewer |
|---|
| → studied in | NCT02542293Phase 3 · active not recruiting Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) · 14 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07168668Phase 2 · not yet recruiting Partial Immune-boost TACE in unrEseCTable HCC Patients Under Systemic Treatment · 14 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03911557Phase 2 · completed Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors · 14 trials list this drug (4 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05932199Phase 1/Phase 2 · recruiting Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma · 14 trials list this drug (4 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03385655Phase 2 · active not recruiting Prostate Cancer Biomarker Enrichment and Treatment Selection · 14 trials list this drug (4 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03802747Phase 1 · withdrawn Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases · 14 trials list this drug (4 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02937818Phase 2 · completed A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer · 14 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06446570Phase 2 · completed Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma · 14 trials list this drug (4 active) | — | — | Head and Neck Neoplasm,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03022500Phase 2 · completed Pulmonary sarcomatoid_MEDI4736+Treme · 14 trials list this drug (4 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03317457Phase 2 · completed Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma · 14 trials list this drug (4 active) | — | — | Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03737968Phase 2 · unknown Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients. · 14 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03292250Phase 2 · completed Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)] · 14 trials list this drug (4 active) | — | — | Head and Neck Neoplasm,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03430895Phase 2 · completed Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract · 14 trials list this drug (4 active) | — | — | Bladder Neoplasm,Bladder Squamous Cell Carcinoma,Malignant Bladder Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978482Phase 1 · completed A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies · 14 trials list this drug (4 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |